These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 23283547)

  • 1. A practical and efficient cellular substrate for the generation of induced pluripotent stem cells from adults: blood-derived endothelial progenitor cells.
    Geti I; Ormiston ML; Rouhani F; Toshner M; Movassagh M; Nichols J; Mansfield W; Southwood M; Bradley A; Rana AA; Vallier L; Morrell NW
    Stem Cells Transl Med; 2012 Dec; 1(12):855-65. PubMed ID: 23283547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell type of origin influences iPSC generation and differentiation to cells of the hematoendothelial lineage.
    Phetfong J; Supokawej A; Wattanapanitch M; Kheolamai P; U-Pratya Y; Issaragrisil S
    Cell Tissue Res; 2016 Jul; 365(1):101-12. PubMed ID: 26893154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative transcriptomic analysis of endothelial progenitor cells derived from umbilical cord blood and adult peripheral blood: Implications for the generation of induced pluripotent stem cells.
    Gao X; Yourick JJ; Sprando RL
    Stem Cell Res; 2017 Dec; 25():202-212. PubMed ID: 29156376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of Human Induced Pluripotent Stem Cells Using Endothelial Progenitor Cells Derived from Umbilical Cord Blood and Adult Peripheral Blood.
    Gao X; Yourick JJ; Sprando RL
    Methods Mol Biol; 2022; 2454():381-396. PubMed ID: 33733392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34
    Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M
    Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically compatible advances in blood-derived endothelial progenitor cell isolation and reprogramming for translational applications.
    Eminli S; Kwieder B; Yi K; Huang CJZ; Moon JI; Chang CH; Kiskin FN; Morrell NW; Hamilton B; Rana AA
    N Biotechnol; 2021 Jul; 63():1-9. PubMed ID: 33588094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus.
    Ye H; Wang Q
    Cell Physiol Biochem; 2018; 50(4):1318-1331. PubMed ID: 30355953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells.
    Hu K; Yu J; Suknuntha K; Tian S; Montgomery K; Choi KD; Stewart R; Thomson JA; Slukvin II
    Blood; 2011 Apr; 117(14):e109-19. PubMed ID: 21296996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feeder-independent derivation of induced-pluripotent stem cells from peripheral blood endothelial progenitor cells.
    Chang WY; Lavoie JR; Kwon SY; Chen Z; Manias JL; Behbahani J; Ling V; Kandel RA; Stewart DJ; Stanford WL
    Stem Cell Res; 2013 Mar; 10(2):195-202. PubMed ID: 23291290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of Induced Pluripotent Stem Cells from Erythroid Progenitor Cells.
    Aksoy ZB; Akcali KC
    Methods Mol Biol; 2024; 2835():99-110. PubMed ID: 39105909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells.
    Ohmine S; Dietz AB; Deeds MC; Hartjes KA; Miller DR; Thatava T; Sakuma T; Kudva YC; Ikeda Y
    Stem Cell Res Ther; 2011 Nov; 2(6):46. PubMed ID: 22088171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reprogramming of blood cells into induced pluripotent stem cells as a new cell source for cartilage repair.
    Li Y; Liu T; Van Halm-Lutterodt N; Chen J; Su Q; Hai Y
    Stem Cell Res Ther; 2016 Feb; 7():31. PubMed ID: 26883322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of iPSCs as a Pooled Culture Using Magnetic Activated Cell Sorting of Newly Reprogrammed Cells.
    Yang W; Liu Y; Slovik KJ; Wu JC; Duncan SA; Rader DJ; Morrisey EE
    PLoS One; 2015; 10(8):e0134995. PubMed ID: 26281015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood.
    Zhou H; Martinez H; Sun B; Li A; Zimmer M; Katsanis N; Davis EE; Kurtzberg J; Lipnick S; Noggle S; Rao M; Chang S
    Stem Cell Rev Rep; 2015 Aug; 11(4):652-65. PubMed ID: 25951995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Overview on Promising Somatic Cell Sources Utilized for the Efficient Generation of Induced Pluripotent Stem Cells.
    Ray A; Joshi JM; Sundaravadivelu PK; Raina K; Lenka N; Kaveeshwar V; Thummer RP
    Stem Cell Rev Rep; 2021 Dec; 17(6):1954-1974. PubMed ID: 34100193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular Reprogramming Allows Generation of Autologous Hematopoietic Progenitors From AML Patients That Are Devoid of Patient-Specific Genomic Aberrations.
    Salci KR; Lee JH; Laronde S; Dingwall S; Kushwah R; Fiebig-Comyn A; Leber B; Foley R; Dal Cin A; Bhatia M
    Stem Cells; 2015 Jun; 33(6):1839-49. PubMed ID: 25764124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ROCK inhibition facilitates the generation of human-induced pluripotent stem cells in a defined, feeder-, and serum-free system.
    Lai WH; Ho JC; Lee YK; Ng KM; Au KW; Chan YC; Lau CP; Tse HF; Siu CW
    Cell Reprogram; 2010 Dec; 12(6):641-53. PubMed ID: 20858051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing Induced Pluripotent Stem Cell Generation by MicroRNA.
    Dang J; Rana TM
    Methods Mol Biol; 2016; 1357():71-84. PubMed ID: 25687299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of disease-specific induced pluripotent stem cells from patients with rheumatoid arthritis and osteoarthritis.
    Lee J; Kim Y; Yi H; Diecke S; Kim J; Jung H; Rim YA; Jung SM; Kim M; Kim YG; Park SH; Kim HY; Ju JH
    Arthritis Res Ther; 2014 Feb; 16(1):R41. PubMed ID: 24490617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.